default author photo

Noriko Mitome

National Cancer Center Hospital

Research Center for Cancer Prevention and Screenin

Tokyo

Japan

  • National Cancer Center Hospital

SCHOLARLY PAPERS

5

DOWNLOADS

176

TOTAL CITATIONS

0

Scholarly Papers (5)

Actions:
Email selected abstracts
1.

Daily low-dose carboplatin or weekly carboplatin plus nab-paclitaxel for concurrent chemoradiotherapy in older patients with locally advanced non-small cell lung cancer (JCOG1914): A randomized phase 3 trial

Number of pages: 42 Posted: 05 Dec 2025
Shota Omori, Hirotsugu Kenmotsu, Shogo Nomura, Hideyuki Harada, Satoshi Ishikura, Masahiro Konno, Masahiko Ando, Hiroki Izumi, Yuki Shinno, Masahide Oki, Takeshi Masuda, Toshihide Yokoyama, Yukio Hosomi, Yukiko Nakamura, Shuji Murakami, Takashi Kurosaki, Hiroshige Yoshioka, Koichi Azuma, Kazuya Tsubouchi, Hiroshi Nokihara, Satoru Miura, Haruko Daga, Hironori Yoshida, Satoshi Hirano, Noriko Mitome, Haruhiko Fukuda, Isamu Okamoto and Toshiaki Takahashi
affiliation not provided to SSRN, Shizuoka Cancer Center - Division of Thoracic Oncology, University of Tokyo - Department of Biostatistics and Bioinformatics, Shizuoka Cancer Center, affiliation not provided to SSRN, Shizuoka Cancer Center, Nagoya University, National Cancer Center Hospital East, National Cancer Center Hospital, National Hospital Organization Nagoya Medical Center, Hiroshima University - Hiroshima University Hospital, Kurashiki Central Hospital - Department of Respiratory Medicine, affiliation not provided to SSRN, affiliation not provided to SSRN, Kanagawa Cancer Center, affiliation not provided to SSRN, Kansai Medical University, Kurume University - Department of Internal Medicine, Kyushu University, National Center for Global Health and Medicine, Niigata Cancer Center Hospital, Osaka City General Hospital, Kyoto University, affiliation not provided to SSRN, National Cancer Center Hospital, National Cancer Center Hospital, Kyushu University - Kyushu University Hospital and Shizuoka Cancer Center
Downloads 61 (1,031,043)

Abstract:

Loading...

locally advanced, Non-small cell lung cancer (NSCLC), older patients, chemoradiotherapy, daily low-dose carboplatin, carboplatin plus nab-paclitaxel

2.

Development of prediction model for zone-specific lymph node metastasis in clinical stage I–II non-small cell lung cancer: a supplementary analysis of Japan Clinical Oncology Group study 1413

Number of pages: 53 Posted: 03 Nov 2025
Mitsuhiro Isaka, Tomoyuki Hishida, Hisashi Saji, Masashi Wakabayashi, Yasuhisa Ohde, Yasuhiro Tsutani, Makoto Endo, Takahiro Mimae, Tomohiro Miyoshi, Tetsuya Isaka, Aritoshi Hattori, Hiroshige Yoshioka, Ryu Nakajima, Masaya Yotsukura, Tomohiro Maniwa, Kazuo Nakagawa, Noriko Mitome, Yuta Sekino, Haruhiko Fukuda, Keiju Aokage, Shun-ichi Watanabe and Morihito Okada
Shizuoka Cancer Center, affiliation not provided to SSRN, affiliation not provided to SSRN, National Cancer Center Hospital, Shizuoka Cancer Center, Hiroshima University, Yamagata Prefectural Central Hospital, Hiroshima University, affiliation not provided to SSRN, Kanagawa Cancer Center, Juntendo University, Kansai Medical University, Osaka City General Hospital - Department of Thoracic Surgery, National Cancer Center Hospital, Osaka International Cancer Institute, affiliation not provided to SSRN, National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital, affiliation not provided to SSRN, National Cancer Center Hospital - Department of Thoracic Surgery and Hiroshima University - Department of Surgical oncology
Downloads 40 (1,196,171)

Abstract:

Loading...

non-small cell lung cancer, clinical stage I-II, Lymph node metastasis, prediction model, lymph node dissection, Nomogram

3.

A multi-institutional randomized phase III trial of Neoadjuvant Chemoimmunotherapy Followed by Surgery versus Upfront Surgery in Patients with Resectable Clinical Stage II-III Non-small cell Lung Cancer: JCOG2317 (NATCH-ICI)

Number of pages: 21 Posted: 31 Mar 2026
Noriko Mitome, Akira Hamada, Masashi Wakabayashi, Takeshi Uozumi, Hidehito Horinouchi, Mitsuhiro Isaka, Masaya Yotsukura, Keiju Aokage, Haruhiko Fukuda, Shun-ichi Watanabe and Yasuhiro Tsutani
National Cancer Center Hospital, Kindai University, National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital, Shizuoka Cancer Center, National Cancer Center Hospital, affiliation not provided to SSRN, National Cancer Center Hospital, National Cancer Center Hospital - Department of Thoracic Surgery and Kindai University
Downloads 38 (1,277,121)

Abstract:

Loading...

Non-small-cell lung cancer, neoadjuvant therapy, adjuvant therapy, immunotherapy, Clinical trial

4.

Adjuvant Chemotherapy Intensity and Prognosis in Completely Resected High-Grade Neuroendocrine Lung Carcinoma: A Post Hoc Analysis of JCOG1205/1206

Number of pages: 43 Posted: 22 Apr 2026
Tetsuya Isaka, Hirotsugu Kenmotsu, Masashi Wakabayashi, Hiroshige Yoshioka, Yoshihisa Shimada, Yasuhiro Tsutani, Kazuo Nakagawa, Masaya Yotsukura, Noriko Mitome, Takeshi Uozumi, Haruko Daga, Hiroshi Tanaka, Takashi Kasai, Seiji Niho, Masahiro Tsuboi, Haruhiko Fukuda, Keiju Aokage, Isamu Okamoto and Shun-ichi Watanabe
Kanagawa Cancer Center, Shizuoka Cancer Center - Division of Thoracic Oncology, National Cancer Center Hospital, Kansai Medical University, University of Tokyo - Department of Surgery, Hiroshima University, affiliation not provided to SSRN, National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital, Osaka City General Hospital, Niigata Cancer Center Hospital, affiliation not provided to SSRN, Dokkyo Medical University, National Cancer Center Hospital East - Department of Thoracic Surgery, National Cancer Center Hospital, affiliation not provided to SSRN, Kyushu University - Kyushu University Hospital and National Cancer Center Hospital - Department of Thoracic Surgery
Downloads 21 (1,470,786)

Abstract:

Loading...

high-grade neuroendocrine carcinoma, Small-cell lung cancer, large-cell neuroendocrine carcinoma, cisplatin, irinotecan, etoposide, Relative dose intensity

5.

A multicenter randomized phase III trial comparing MET tyrosine kinase inhibitors versus immune checkpoint inhibitors with or without chemotherapy as first-line treatment for patients with advanced non-small cell lung cancer harboring MET exon 14 skipping mutations: JCOG2506 (DECIDE-MET)

Number of pages: 18 Posted: 02 Jul 2026
Noriko Mitome, Kei Kunimasa, Shogo Nomura, Kota Kawabata, Ken Masuda, Yoshimasa Shiraishi, Hirotsugu Kenmotsu, Masahiko Ando, Haruhiko Fukuda, Isamu Okamoto and Yasushi Goto
National Cancer Center Hospital, Osaka International Cancer Institute, University of Tokyo - Department of Biostatistics and Bioinformatics, National Cancer Center Hospital, National Cancer Center Hospital, Kyushu University, Shizuoka Cancer Center - Division of Thoracic Oncology, Nagoya University - Department of Advanced Medicine, National Cancer Center Hospital, Kyushu University - Kyushu University Hospital and National Cancer Center Hospital
Downloads 16

Abstract:

Loading...

advanced non-small cell lung cancer, MET exon 14 skipping mutations, MET inhibitors, immune checkpoint inhibitor, non-inferiority trial